CONMED Corporation (CNMD)
USD 51.87
(-6.42%)
USD 51.87
(-6.42%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 971.48 Million USD | -1.38% |
| 2022 | 985.07 Million USD | 46.5% |
| 2021 | 672.4 Million USD | -10.34% |
| 2020 | 749.97 Million USD | -0.69% |
| 2019 | 755.21 Million USD | 72.2% |
| 2018 | 438.56 Million USD | -7.03% |
| 2017 | 471.74 Million USD | -3.39% |
| 2016 | 488.28 Million USD | 81.2% |
| 2015 | 269.47 Million USD | 12.19% |
| 2014 | 240.2 Million USD | 12.02% |
| 2013 | 214.43 Million USD | 33.35% |
| 2012 | 160.8 Million USD | 80.77% |
| 2011 | 88.95 Million USD | 4.43% |
| 2010 | 85.18 Million USD | -53.25% |
| 2009 | 182.19 Million USD | -7.13% |
| 2008 | 196.19 Million USD | -10.61% |
| 2007 | 219.48 Million USD | -17.07% |
| 2006 | 264.67 Million USD | -12.55% |
| 2005 | 302.64 Million USD | 4.19% |
| 2004 | 290.48 Million USD | 11.53% |
| 2003 | 260.44 Million USD | 2.23% |
| 2002 | 254.75 Million USD | -2.95% |
| 2001 | 262.5 Million USD | -23.4% |
| 2000 | 342.68 Million USD | -5.28% |
| 1999 | 361.8 Million USD | -0.03% |
| 1998 | 361.9 Million USD | 2.23% |
| 1997 | 354 Million USD | 0.0% |
| 1996 | - USD | -100.0% |
| 1995 | 27.8 Million USD | 302.9% |
| 1994 | 6.9 Million USD | -26.6% |
| 1993 | 9.4 Million USD | 0.0% |
| 1992 | - USD | -100.0% |
| 1991 | 100 Thousand USD | -97.96% |
| 1990 | 4.9 Million USD | -7.55% |
| 1989 | 5.3 Million USD | 960.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 965.17 Million USD | -2.52% |
| 2024 Q3 | 940.09 Million USD | -2.6% |
| 2024 Q1 | 990.11 Million USD | 1.92% |
| 2023 Q2 | 971.47 Million USD | -2.39% |
| 2023 Q1 | 995.27 Million USD | 1.04% |
| 2023 Q3 | 942.16 Million USD | -3.02% |
| 2023 Q4 | 971.48 Million USD | 3.11% |
| 2023 FY | 971.48 Million USD | -1.38% |
| 2022 Q3 | 1.03 Billion USD | 5.5% |
| 2022 FY | 985.07 Million USD | 46.5% |
| 2022 Q2 | 982.42 Million USD | 39.64% |
| 2022 Q4 | 985.07 Million USD | -4.96% |
| 2022 Q1 | 703.54 Million USD | 4.63% |
| 2021 Q3 | 703.33 Million USD | -0.63% |
| 2021 FY | 672.4 Million USD | -10.34% |
| 2021 Q1 | 725.32 Million USD | -3.29% |
| 2021 Q2 | 707.8 Million USD | -2.41% |
| 2021 Q4 | 672.4 Million USD | -4.4% |
| 2020 Q4 | 749.97 Million USD | -1.38% |
| 2020 FY | 749.97 Million USD | -0.69% |
| 2020 Q3 | 760.45 Million USD | -3.79% |
| 2020 Q2 | 790.42 Million USD | 2.3% |
| 2020 Q1 | 772.63 Million USD | 2.31% |
| 2019 FY | 755.21 Million USD | 72.2% |
| 2019 Q3 | 780.68 Million USD | -1.94% |
| 2019 Q4 | 755.21 Million USD | -3.26% |
| 2019 Q2 | 796.14 Million USD | -0.92% |
| 2019 Q1 | 803.55 Million USD | 83.22% |
| 2018 Q3 | 442.9 Million USD | 2.47% |
| 2018 FY | 438.56 Million USD | -7.03% |
| 2018 Q1 | 442.4 Million USD | -6.22% |
| 2018 Q2 | 432.23 Million USD | -2.3% |
| 2018 Q4 | 438.56 Million USD | -0.98% |
| 2017 Q4 | 471.74 Million USD | -4.66% |
| 2017 Q2 | 484.03 Million USD | -0.62% |
| 2017 Q1 | 487.04 Million USD | -0.25% |
| 2017 Q3 | 494.78 Million USD | 2.22% |
| 2017 FY | 471.74 Million USD | -3.39% |
| 2016 Q1 | 511.59 Million USD | 89.85% |
| 2016 Q3 | 490.17 Million USD | -3.63% |
| 2016 Q2 | 508.63 Million USD | -0.58% |
| 2016 FY | 488.28 Million USD | 81.2% |
| 2016 Q4 | 488.28 Million USD | -0.39% |
| 2015 Q2 | 258.54 Million USD | 0.52% |
| 2015 FY | 269.47 Million USD | 12.19% |
| 2015 Q1 | 257.2 Million USD | 7.08% |
| 2015 Q4 | 269.47 Million USD | 3.43% |
| 2015 Q3 | 260.54 Million USD | 0.77% |
| 2014 FY | 240.2 Million USD | 12.02% |
| 2014 Q4 | 240.2 Million USD | -2.69% |
| 2014 Q1 | 241.43 Million USD | 12.59% |
| 2014 Q2 | 244.83 Million USD | 1.41% |
| 2014 Q3 | 246.83 Million USD | 0.82% |
| 2013 Q3 | 224.01 Million USD | -3.86% |
| 2013 Q4 | 214.43 Million USD | -4.28% |
| 2013 Q2 | 233.01 Million USD | 3.65% |
| 2013 Q1 | 224.8 Million USD | 39.8% |
| 2013 FY | 214.43 Million USD | 33.35% |
| 2012 Q4 | 160.8 Million USD | -4.53% |
| 2012 FY | 160.8 Million USD | 80.77% |
| 2012 Q2 | 145.43 Million USD | 4.67% |
| 2012 Q1 | 138.95 Million USD | 56.21% |
| 2012 Q3 | 168.43 Million USD | 15.81% |
| 2011 Q3 | 9.11 Million USD | -70.24% |
| 2011 Q1 | 71.84 Million USD | -15.66% |
| 2011 Q2 | 30.64 Million USD | -57.35% |
| 2011 Q4 | 88.95 Million USD | 875.46% |
| 2011 FY | 88.95 Million USD | 4.43% |
| 2010 Q2 | 170.36 Million USD | -2.04% |
| 2010 Q4 | 85.18 Million USD | -50.21% |
| 2010 Q1 | 173.91 Million USD | -4.55% |
| 2010 Q3 | 171.08 Million USD | 0.42% |
| 2010 FY | 85.18 Million USD | -53.25% |
| 2009 FY | 182.19 Million USD | -7.13% |
| 2009 Q3 | 182.91 Million USD | -0.72% |
| 2009 Q4 | 182.19 Million USD | -0.39% |
| 2009 Q2 | 184.23 Million USD | -1.37% |
| 2009 Q1 | 186.78 Million USD | -4.79% |
| 2008 Q4 | 196.19 Million USD | -9.87% |
| 2008 Q3 | 217.67 Million USD | -3.17% |
| 2008 Q2 | 224.79 Million USD | 2.48% |
| 2008 FY | 196.19 Million USD | -10.61% |
| 2008 Q1 | 219.36 Million USD | -0.06% |
| 2007 Q4 | 219.48 Million USD | -8.41% |
| 2007 FY | 219.48 Million USD | -17.07% |
| 2007 Q1 | 256.88 Million USD | -2.94% |
| 2007 Q2 | 237.78 Million USD | -7.44% |
| 2007 Q3 | 239.64 Million USD | 0.79% |
| 2006 Q2 | 296.9 Million USD | -0.18% |
| 2006 Q3 | 296.75 Million USD | -0.05% |
| 2006 Q4 | 264.67 Million USD | -10.81% |
| 2006 FY | 264.67 Million USD | -12.55% |
| 2006 Q1 | 297.42 Million USD | -1.72% |
| 2005 Q2 | 269.42 Million USD | -2.85% |
| 2005 FY | 302.64 Million USD | 4.19% |
| 2005 Q4 | 302.64 Million USD | 13.37% |
| 2005 Q1 | 277.33 Million USD | -4.53% |
| 2005 Q3 | 266.95 Million USD | -0.92% |
| 2004 FY | 290.48 Million USD | 11.53% |
| 2004 Q1 | 237.5 Million USD | -8.81% |
| 2004 Q2 | 236.39 Million USD | -0.47% |
| 2004 Q3 | 285.99 Million USD | 20.98% |
| 2004 Q4 | 290.48 Million USD | 1.57% |
| 2003 FY | 260.44 Million USD | 2.23% |
| 2003 Q2 | 285.45 Million USD | 0.88% |
| 2003 Q1 | 282.94 Million USD | 11.07% |
| 2003 Q4 | 260.44 Million USD | -5.94% |
| 2003 Q3 | 276.88 Million USD | -3.0% |
| 2002 Q4 | 254.75 Million USD | 1.27% |
| 2002 Q1 | 252.07 Million USD | -3.97% |
| 2002 FY | 254.75 Million USD | -2.95% |
| 2002 Q2 | 179 Million USD | -28.99% |
| 2002 Q3 | 251.56 Million USD | 40.53% |
| 2001 FY | 262.5 Million USD | -23.4% |
| 2001 Q4 | 262.5 Million USD | -24.75% |
| 2001 Q3 | 348.82 Million USD | 5.69% |
| 2001 Q2 | 330.03 Million USD | -1.73% |
| 2001 Q1 | 335.85 Million USD | -1.99% |
| 2000 FY | 342.68 Million USD | -5.28% |
| 2000 Q2 | 345.73 Million USD | -2.27% |
| 2000 Q3 | 353.7 Million USD | 2.31% |
| 2000 Q4 | 342.68 Million USD | -3.12% |
| 2000 Q1 | 353.76 Million USD | -2.22% |
| 1999 Q2 | 341.5 Million USD | -3.69% |
| 1999 Q3 | 375 Million USD | 9.81% |
| 1999 Q4 | 361.8 Million USD | -3.52% |
| 1999 FY | 361.8 Million USD | -0.03% |
| 1999 Q1 | 354.6 Million USD | -2.02% |
| 1998 Q3 | 347.8 Million USD | 2.17% |
| 1998 Q4 | 361.9 Million USD | 4.05% |
| 1998 FY | 361.9 Million USD | 2.23% |
| 1998 Q1 | 353.6 Million USD | -0.11% |
| 1998 Q2 | 340.4 Million USD | -3.73% |
| 1997 Q4 | 354 Million USD | 0.0% |
| 1997 FY | 354 Million USD | 0.0% |
| 1997 Q1 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1996 FY | - USD | -100.0% |
| 1996 Q1 | 3.7 Million USD | -86.69% |
| 1996 Q2 | 3.2 Million USD | -13.51% |
| 1996 Q3 | 3 Million USD | -6.25% |
| 1996 Q4 | - USD | -100.0% |
| 1995 FY | 27.8 Million USD | 302.9% |
| 1995 Q2 | 33.2 Million USD | 58.85% |
| 1995 Q3 | 31 Million USD | -6.63% |
| 1995 Q4 | 27.8 Million USD | -10.32% |
| 1995 Q1 | 20.9 Million USD | 202.9% |
| 1994 Q4 | 6.9 Million USD | -8.0% |
| 1994 Q1 | 8.1 Million USD | -13.83% |
| 1994 Q2 | 7.5 Million USD | -7.41% |
| 1994 Q3 | 7.5 Million USD | 0.0% |
| 1994 FY | 6.9 Million USD | -26.6% |
| 1993 Q4 | 9.4 Million USD | -6.0% |
| 1993 Q3 | 10 Million USD | 0.0% |
| 1993 Q1 | - USD | 0.0% |
| 1993 FY | 9.4 Million USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1992 Q2 | 100 Thousand USD | 0.0% |
| 1992 Q4 | - USD | -100.0% |
| 1992 Q1 | 100 Thousand USD | 0.0% |
| 1992 FY | - USD | -100.0% |
| 1992 Q3 | 100 Thousand USD | 0.0% |
| 1991 Q2 | 200 Thousand USD | -95.65% |
| 1991 Q3 | 200 Thousand USD | 0.0% |
| 1991 FY | 100 Thousand USD | -97.96% |
| 1991 Q4 | 100 Thousand USD | -50.0% |
| 1991 Q1 | 4.6 Million USD | -6.12% |
| 1990 Q3 | 5.1 Million USD | -3.77% |
| 1990 Q1 | 5.3 Million USD | 0.0% |
| 1990 Q4 | 4.9 Million USD | -3.92% |
| 1990 FY | 4.9 Million USD | -7.55% |
| 1990 Q2 | 5.3 Million USD | 0.0% |
| 1989 Q3 | 5.4 Million USD | 0.0% |
| 1989 Q4 | 5.3 Million USD | -1.85% |
| 1989 FY | 5.3 Million USD | 960.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Abbott Laboratories | 13.59 Billion USD | 92.856% |
| Allurion Technologies Inc. | 2.3 Million USD | -42028.491% |
| Artivion, Inc. | 305.53 Million USD | -217.965% |
| Avanos Medical, Inc. | 159.4 Million USD | -509.462% |
| Butterfly Network, Inc. | 22.83 Million USD | -4154.36% |
| Butterfly Network, Inc. | 22.83 Million USD | -4154.36% |
| Bio-Rad Laboratories, Inc. | 1.18 Billion USD | 18.325% |
| Boston Scientific Corporation | 8.96 Billion USD | 89.159% |
| Edwards Lifesciences Corporation | 670 Million USD | -44.997% |
| Paragon 28, Inc. | 109.79 Million USD | -784.783% |
| Glaukos Corporation | 383.73 Million USD | -153.163% |
| Globus Medical, Inc. | 417.4 Million USD | -132.746% |
| Inspire Medical Systems, Inc. | 24.84 Million USD | -3810.018% |
| Integer Holdings Corporation | 959.92 Million USD | -1.204% |
| Medtronic plc | 23.87 Billion USD | 95.931% |
| Myomo, Inc. | 115.16 Thousand USD | -843494.13% |
| Nevro Corp. | 211.47 Million USD | -359.393% |
| Owlet, Inc. | 22 Thousand USD | -4415731.818% |
| Penumbra, Inc. | 220.9 Million USD | -339.766% |
| Vicarious Surgical Inc. | 13.78 Million USD | -6947.392% |
| Smith & Nephew plc | 2.17 Billion USD | 55.334% |
| Sonendo, Inc. | 14.03 Million USD | -6821.86% |
| STERIS plc | 3.12 Billion USD | 68.864% |
| Stryker Corporation | 10.9 Billion USD | 91.088% |
| Vapotherm, Inc. | 109.97 Million USD | -783.343% |
| Zimmer Biomet Holdings, Inc. | 4.86 Billion USD | 80.043% |